Leap Therapeutics Makes a Bold Move: $18 Million Invested Into Privacy Coin Zcash
In an unexpected shift toward privacy-focused crypto assets, Nasdaq-listed biotech firm Leap Therapeutics (LPTX) has made a major purchase of Zcash (ZEC).
The company acquired 29,869 ZEC for roughly $18 million, entering the market at an average price of $602.63 per token.
This latest buy brings Leap’s total Zcash holdings to a substantial 232,644 ZEC, placing the firm among the largest publicly disclosed corporate holders of the privacy coin.
The move highlights Leap Therapeutics’ belief that:
Privacy protocols are currently undervalued, and
$ZEC has strong potential for a rebound from current levels
With an average entry near $602, the company appears to be taking a confident, contrarian value position—especially considering Zcash’s underperformance compared to broader market leaders.
This growing ZEC allocation also serves as a rare form of diversification within corporate treasuries, which typically focus heavily on $BTC and $ETH .
Follow for more crypto and market updates.
#BTC90kBreakingPoint #USStocksForecast2026 #StrategyBTCPurchase
